A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)

Clinical trial NCT06340490 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06340490
Sponsor: Guangdong Ruishun Biotech Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2024-05-15
Primary completion: 2026-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.